Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Clinical Decision Tree to Predict Whether a Bacteremic Patient Is Infected With an Extended-Spectrum β-Lactamase–Producing Organism

28 Jun 2016

Abstract excerpt

BACKGROUND: Timely identification of extended-spectrum β-lactamase (ESBL) bacteremia can improve clinical outcomes while minimizing unnecessary use of broad-spectrum antibiotics, including carbapenems. However, most clinical microbiology laboratories currently require at least 24 additional hours from the time of microbial genus and species identification to confirm ESBL production. Our objective was to develop a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibiotic Resistance in Bacteria
Share to Antibiotics Pharmacokinetics and Efficacy
Share to Bacterial Identification and Susceptibility Testing

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27358356
DOI: 10.1093/cid/ciw425

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 9 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Clinical Decision Tree to Predict Whether a Bacteremic Patient Is Infected With an Extended-Spectrum β-Lactamase–Producing OrganismPMID 27358356Read ↗

Diagnostic prediction tools for bacteraemia caused by 3rd generation cephalosporin-resistant Enterobacteriaceae in suspected bacterial infections: a nested case-control studySemantic proximity Read ↗

Advancing Carbapenem-Resistant K. pneumoniae Risk Factor and Prognosis Analysis: A Comparative Study of Machine Learning Techniques Over Traditional Statistical MethodSemantic proximity Read ↗

Integrated evaluation of rapid diagnostic testing, genotypic-phenotypic resistance profiling, and AI-Assisted prediction models for antimicrobial stewardship and clinical outcomes in a resource-limited setting.Semantic proximity Read ↗

Extended Spectrum beta-Lactamase Bacteria and Multidrug Resistance in Jordan are Predicted Using a New Machine-Learning systemSemantic proximity Read ↗

Evaluating the cost-effectiveness of rapid diagnostic testing for the identification of pathogens and resistance genes in bloodstream infectionsSemantic proximity Read ↗

Development and validation of machine learning-based models for predicting healthcare-associated bacterial/fungal infections among COVID-19 inpatients: a retrospective cohort studySemantic proximity Read ↗

Patient-specific antibiotic susceptibility ranking for empirical treatment of gram-negative bloodstream infection: a retrospective clinical decision-support and transportability studySemantic proximity Read ↗

Integrating Phenotypic and Genomic Data with Machine Learning to Predict Antimicrobial Resistance and Identify Genetic Biomarkers in E. coli.Semantic proximity Read ↗

Artificial Intelligence model to predict resistances in Gram-negative bloodstream infectionsSemantic proximity Read ↗

A Multi-Criteria Decision Analysis-based Framework for Assessing and Prioritizing Antimicrobial Resistance Risks from Metagenomic DatasetsSemantic proximity Read ↗

Comparison of Predictors and Mortality Between Bloodstream Infections Caused by ESBL-Producing Escherichia coli and ESBL-Producing Klebsiella pneumoniae.Semantic proximity Read ↗

Machine learning-based lineage prediction from antimicrobial susceptibility testing phenotypes for Escherichia coli sequence type 131 clade C surveillance across infection types.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.